Literature DB >> 6278136

Leukotrienes C4, D4 and E4: effects on human and guinea-pig cardiac preparations in vitro.

J A Burke, R Levi, Z G Guo, E J Corey.   

Abstract

The effects of leukotrienes C4, D4 and E4 (LT C4, D4 and E4) were studied in isolated preparations of guinea-pig and human myocardium in order to assess their contribution to cardiac dysfunction associated with systemic anaphylaxis. LT C4, D4 and E4 all caused long-lasting and dose-related decreases in the contractile force and coronary flow rate of the isolated guinea-pig heart. The rank order of potency was LT D4 greater than C4 greater than E4. The effects of LT C4 and D4 were antagonized by the anti-slow-reacting-substance compound FPL 55712. The negative inotropic effect of LT is unlikely to be secondary to the concomitant reduction in coronary flow because: 1) the same reduction in coronary flow by angiotensin II resulted in a negligible decrease in contractility and 2) the negative inotropic effect of LT also occurred in the electrically paced, noncoronary perfused left atrium and right ventricular papillary muscle of the guinea pig and in pectinate muscles obtained from surgical specimens of human right atrial appendage. LT D4 potentiated the positive chronotropic effect of histamine, supporting the concept that functional interactions occur between the various mediators of immediate hypersensitivity. The cardiac effects of pure synthetic LT are similar to those previously obtained with crude slow-reacting substance of anaphylaxis indicating that the prolonged contractile failure associated with systemic anaphylaxis largely could be due to the negative inotropic effect of LT. Because LT are released in a variety of immunological and inflammatory reactions, their potent myocardial depressant effects may play a role in cardiac dysfunction associated with these reactions.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6278136

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  33 in total

Review 1.  Leukotriene receptors.

Authors:  S E Dahlén
Journal:  Clin Rev Allergy Immunol       Date:  1999 Spring-Summer       Impact factor: 8.667

2.  Pharmacological characterization of the first potent and selective antagonist at the cysteinyl leukotriene 2 (CysLT(2)) receptor.

Authors:  F Wunder; H Tinel; R Kast; A Geerts; E M Becker; P Kolkhof; J Hütter; J Ergüden; M Härter
Journal:  Br J Pharmacol       Date:  2010-05       Impact factor: 8.739

3.  Effect of azelastine on bronchoconstriction induced by histamine and leukotriene C4 in patients with extrinsic asthma.

Authors:  M K Albazzaz; K R Patel
Journal:  Thorax       Date:  1988-04       Impact factor: 9.139

4.  Cardiac dysfunction caused by purified human C3a anaphylatoxin.

Authors:  U H del Balzo; R Levi; M J Polley
Journal:  Proc Natl Acad Sci U S A       Date:  1985-02       Impact factor: 11.205

5.  Immunological and non-immunological release of leukotrienes and histamine by guinea-pig heart.

Authors:  H Salari
Journal:  Immunology       Date:  1986-07       Impact factor: 7.397

6.  The comparative effects of dietary alpha-linolenic acid and fish oil on 4- and 5-series leukotriene formation in vivo.

Authors:  J Whelan; K S Broughton; J E Kinsella
Journal:  Lipids       Date:  1991-02       Impact factor: 1.880

7.  Effects of a new thromboxane A2-antagonist (ONO-3708) and a new leukotriene-antagonist (ONO-1078) on thromboxane A2 analogue-, leukotriene C4-, and D4-induced regional myocardial blood flow reduction.

Authors:  T Torii; Y Toki; N Hieda; Y Ito; K Okumura; H Hashimoto; T Ito; K Ogawa; T Satake
Journal:  Heart Vessels       Date:  1988       Impact factor: 2.037

8.  Renal vascular effects of leukotriene C4 in the isolated perfused kidney of the rat.

Authors:  J C Frölich; M Yoshizawa
Journal:  Br J Pharmacol       Date:  1987-10       Impact factor: 8.739

Review 9.  Leukotriene receptors as potential therapeutic targets.

Authors:  Takehiko Yokomizo; Motonao Nakamura; Takao Shimizu
Journal:  J Clin Invest       Date:  2018-05-14       Impact factor: 14.808

Review 10.  Leukotrienes, allergy and inflammation.

Authors:  F P Nijkamp; J M Sitsen
Journal:  Pharm Weekbl Sci       Date:  1982-12-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.